Can non-fundable trials be conducted anyway? The case for open, randomised, actively controlled trials in rheumatology

Annals of the Rheumatic Diseases

Volumn 57, Issue 3, 1998, Pages 128-130

  Giannini, Edward H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST; DERMATOMYOSITIS; HEALTH INSURANCE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCLERODERMA; SHORT SURVEY; STATISTICAL ANALYSIS;

EID: 0031780258     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.3.128     Document Type: Short Survey

References (15)

1. Guyatt GH, Rennie D. Users' guides to the medical literature. JAMA 1993;270:2096-7.
2. Pincus T, Stein CM. What is the best source of useful data on the treatment of rheumatoid arthritis: Clinical trials, clinical observations, or clinical protocols? J Rheumatol 1995;22:1611-17.
3. Feldman BM, Giannini EH. Where's the evidence? Putting clinical science into pediatric rheumatology. J Rheumatol 1996;23:1502-4.
4. O'Dell JR. Combination DMARD therapy for rheumatoid arthritis: A step closer to the goal. Ann Rheum Dis 1996;55:781-3.
5. Pediatric Oncology Group. Progress against childhood cancer: the Pediatric Oncology Group experience. Pediatrics 1992;89:597-600.
6. Brophy JM, Joseph L. Placing trials in context using Bayesian analysis: GUSTO revisited by Reverend Bayes. JAMA 1995;273:871-5.
7. Shaikov AV, Maximov AA, Speransky AI, Lovell DJ, Giannini EH, Solovyev SK. Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis Preliminary results of a longterm study. J Rheumatol 1992;19:612-16.
8. LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F. Discrepencies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-42.
9. Bailar JC, III. The promise and problems of meta-analysis. N Engl J Med 1997;337:559-61.
10. Guyatt GH, Sackett DL, Cook DJ, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? JAMA 1993;270:2598-601.
11. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials - The CONSORT statement. JAMA 1996;276:637-9.
12. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
13. Smith MA, Ungerleider RS, Korn EL, Rubinstein L, Simon R. Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute. J Clin Oncol 1997;15:2736-43.
14. Taubes G. Medical Research: Use of placebo controls in clinical trials disputed. Science 1995;267:25-6.
15. Smith M, Simon R, Cain D, Ungerleider RS. Children and cancer. A perspective from the Cancer Therapy Evaluation Program, National Cancer Institute. Cancer 1993;71:3422-8.